-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Leaders of the Standing Committee of the Provincial People’s Congress Conduct a Research Visit to Shijiazhuang No. 4 Pharmaceutical, Striving to Provide Dedicated and Comprehensive Services to Enterprises
Category:
发布时间：2020-07-14
【概要描述】
On July 2, Zhang Meizhi, Vice Chairperson of the Standing Committee of the Provincial People’s Congress, conducted a field inspection of several enterprises in the city’s High-tech Industrial Development Zone. Zhang Meizhi emphasized the need to do everything possible to help businesses overcome the challenges they face in production and operations, thereby promoting their healthy and sustainable development.
On July 2, Zhang Meizhi, Vice Chairperson of the Standing Committee of the Provincial People’s Congress, conducted a field inspection of several enterprises in the city’s High-tech Industrial Development Zone. Zhang Meizhi emphasized the need to do everything possible to help businesses resolve the challenges they encounter in production and operations, thereby promoting their healthy and sustainable development.
Si Cunxi, Director of the Standing Committee of the Municipal People’s Congress, and Li Zhihong, Deputy Director, accompanied the research visit.
Zhang Meizhi and her delegation conducted on-site inspections at Shijiazhuang No. 4 Pharmaceutical Co., Ltd., Shijiazhuang Chengzhi Yonghua Display Materials Co., Ltd., Shijiazhuang Hepai Biotechnology Co., Ltd., and other enterprises, gaining first-hand insights into their production and operations, epidemic prevention and control measures, as well as the challenges and issues they face, while offering suggestions and guidance to help these companies overcome their difficulties.
Zhang Meizhi emphasized the need to make concerted efforts to optimize the business environment, proactively provide high-quality services to enterprises, and support their development. Relevant departments should promptly identify the challenges faced by businesses and do their utmost to coordinate and resolve the difficulties and problems they encounter. It is essential to establish and improve communication mechanisms, fully leverage the functions of government agencies, implement targeted assistance, and bolster enterprise production and operations, thereby providing robust support and serving as a strong backing for business growth.
Zhang Meizhi pointed out that several enterprises have been consistently investing in the cultivation and introduction of new growth drivers, focusing on their core industries and continuously strengthening talent development, thereby demonstrating a robust growth trajectory. Moving forward, it is essential to further leverage the pivotal role of scientific and technological innovation, pool resources from all sectors, intensify efforts in technological innovation and industrial upgrading, and foster and enhance enterprises’ core competitiveness. Talent development must be regarded as a critical component of corporate growth, providing the intellectual support necessary for sustainable expansion. Enterprises should seize opportunities, build on existing momentum, uphold independent innovation, keep pace with the times, take the lead in the new round of high-quality development, and make greater contributions.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091